466 related articles for article (PubMed ID: 1742081)
1. Soluble CD4-PE40 is cytotoxic for a transfected mammalian cell line stably expressing the envelope protein of human immunodeficiency virus (HIV-1), and cytotoxicity is variably inhibited by the sera of HIV-1-infected patients.
Pitts TW; Bohanon MJ; Leach MF; McQuade TJ; Marschke CK; Merritt JA; Wierenga W; Nicholas JA
AIDS Res Hum Retroviruses; 1991 Sep; 7(9):741-50. PubMed ID: 1742081
[TBL] [Abstract][Full Text] [Related]
2. Use of recombinant soluble CD4 Pseudomonas exotoxin, a novel immunotoxin, for treatment of persons infected with human immunodeficiency virus.
Davey RT; Boenning CM; Herpin BR; Batts DH; Metcalf JA; Wathen L; Cox SR; Polis MA; Kovacs JA; Falloon J
J Infect Dis; 1994 Nov; 170(5):1180-8. PubMed ID: 7963711
[TBL] [Abstract][Full Text] [Related]
3. Interdomain interactions in the chimeric protein toxin sCD4(178)-PE40: a differential scanning calorimetry (DSC) study.
Davio SR; Kienle KM; Collins BE
Pharm Res; 1995 May; 12(5):642-8. PubMed ID: 7479546
[TBL] [Abstract][Full Text] [Related]
4. Activity of CD4-Pseudomonas exotoxin against cells expressing diverse forms of the HIV and SIV envelope glycoproteins.
Ashorn P; Moss B; Berger EA
J Acquir Immune Defic Syndr (1988); 1992; 5(1):70-7. PubMed ID: 1738090
[TBL] [Abstract][Full Text] [Related]
5. Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.
Moore JP; McKeating JA; Jones IM; Stephens PE; Clements G; Thomson S; Weiss RA
AIDS; 1990 Apr; 4(4):307-15. PubMed ID: 2190605
[TBL] [Abstract][Full Text] [Related]
6. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
Bower JF; Green TD; Ross TM
Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
[TBL] [Abstract][Full Text] [Related]
7. Recombinant CD4-Pseudomonas exotoxin hybrid protein displays HIV-specific cytotoxicity without affecting MHC class II-dependent functions.
Berger EA; Chaudhary VK; Clouse KA; Jaraquemada D; Nicholas JA; Rubino KL; Fitzgerald DJ; Pastan I; Moss B
AIDS Res Hum Retroviruses; 1990 Jun; 6(6):795-804. PubMed ID: 2114147
[TBL] [Abstract][Full Text] [Related]
8. Effects of a soluble CD4 and CD4-Pseudomonas exotoxin A chimeric protein on human peripheral blood lymphocytes: lymphocyte activation and anti-HIV activity in vitro.
Rubino KL; Tarpley WG; Nicholas JA
Antiviral Res; 1991 Oct; 16(3):267-79. PubMed ID: 1805685
[TBL] [Abstract][Full Text] [Related]
9. Surface expression of the HIV-1 envelope proteins in env gene-transfected CD4-positive human T cell clones: characterization and killing by an antibody-dependent cellular cytotoxic mechanism.
Ahmad A; Yao XA; Tanner JE; Cohen E; Menezes J
J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):789-98. PubMed ID: 7912729
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.
Dey B; Del Castillo CS; Berger EA
J Virol; 2003 Mar; 77(5):2859-65. PubMed ID: 12584309
[TBL] [Abstract][Full Text] [Related]
11. Primary HIV-1 isolates refractory to neutralization by soluble CD4 are potently inhibited by CD4-Pseudomonas exotoxin.
Kennedy PE; Moss B; Berger EA
Virology; 1993 Jan; 192(1):375-9. PubMed ID: 8517027
[TBL] [Abstract][Full Text] [Related]
12. Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.
Moore JP; McKeating JA; Norton WA; Sattentau QJ
J Virol; 1991 Mar; 65(3):1133-40. PubMed ID: 1995942
[TBL] [Abstract][Full Text] [Related]
13. Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120.
Salzwedel K; Smith ED; Dey B; Berger EA
J Virol; 2000 Jan; 74(1):326-33. PubMed ID: 10590121
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a defect of antibody-dependent cellular cytotoxic (ADCC) effector function and anti-HIV gp120/41-specific ADCC-mediating antibody titres in HIV-infected individuals.
Ahmad A; Morisset R; Thomas R; Menezes J
J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):428-37. PubMed ID: 7908983
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 gp120/160 expressing transfected cell clones to evaluate the antibody-dependent cellular cytotoxicity (ADCC) during the course of HIV-1 infection.
Merzouki A; Patel P; Cassol S; O'Shaughnessy M; Gill J; Arella M
J Virol Methods; 1994 Jun; 48(1):9-21. PubMed ID: 7962264
[TBL] [Abstract][Full Text] [Related]
16. Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor.
Brighty DW; Rosenberg M; Chen IS; Ivey-Hoyle M
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7802-5. PubMed ID: 1909031
[TBL] [Abstract][Full Text] [Related]
17. Large-scale immunoaffinity purification of recombinant soluble human antigen CD4 from Escherichia coli cells.
Wells PA; Beiderman B; Garlick RL; Lyle SB; Martin JP; Herberg JT; Meyer HF; Henderson SL; Eckenrode FM
Biotechnol Appl Biochem; 1993 Dec; 18(3):341-57. PubMed ID: 8297511
[TBL] [Abstract][Full Text] [Related]
18. Failure of short-term CD4-PE40 infusions to reduce virus load in human immunodeficiency virus-infected persons.
Ramachandran RV; Katzenstein DA; Wood R; Batts DH; Merigan TC
J Infect Dis; 1994 Oct; 170(4):1009-13. PubMed ID: 7930696
[TBL] [Abstract][Full Text] [Related]
19. CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses.
Berger EA; Clouse KA; Chaudhary VK; Chakrabarti S; FitzGerald DJ; Pastan I; Moss B
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9539-43. PubMed ID: 2480605
[TBL] [Abstract][Full Text] [Related]
20. Elimination of infectious human immunodeficiency virus from human T-cell cultures by synergistic action of CD4-Pseudomonas exotoxin and reverse transcriptase inhibitors.
Ashorn P; Moss B; Weinstein JN; Chaudhary VK; FitzGerald DJ; Pastan I; Berger EA
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8889-93. PubMed ID: 1701055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
